Portunus trituberculatus isolate SZX2019 chromosome 45, ASM1759143v1, whole genome shotgun sequence.
Portunus trituberculatus (swimming crab)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Multicrustacea; Malacostraca; Eumalacostraca; Eucarida; Decapoda; Pleocyemata; Brachyura; Eubrachyura; Portunoidea; Portunidae; Portunus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM030115.1.\nAssembly name: ASM1759143v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Center for Ecological and\nEnvironmental Sciences on 2021/03/30. The original whole-genome\nshotgun project has the accession JAGGDN000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Center for Ecological and Environmental\n Sciences\nAssembly Method :: Wtdbg v. 2.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 54.74x\nSequencing Technology :: Oxford Nanopore; Illumina\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Portunus trituberculatus Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized LOC123519630, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC123519630, transcript variant X1
uncharacterized LOC123519630, transcript variant X3
NAD(+) hydrolase sarm1-like, transcript variant X8
NAD(+) hydrolase sarm1-like, transcript variant X7
NAD(+) hydrolase sarm1-like, transcript variant X11
NAD(+) hydrolase sarm1-like, transcript variant X16
NAD(+) hydrolase sarm1-like, transcript variant X13
NAD(+) hydrolase sarm1-like, transcript variant X15
NAD(+) hydrolase sarm1-like, transcript variant X20
NAD(+) hydrolase sarm1-like, transcript variant X2
NAD(+) hydrolase sarm1-like, transcript variant X1
NAD(+) hydrolase sarm1-like, transcript variant X3
NAD(+) hydrolase sarm1-like, transcript variant X4
NAD(+) hydrolase sarm1-like, transcript variant X5
NAD(+) hydrolase sarm1-like, transcript variant X6
NAD(+) hydrolase sarm1-like, transcript variant X9
NAD(+) hydrolase sarm1-like, transcript variant X10
NAD(+) hydrolase sarm1-like, transcript variant X17
NAD(+) hydrolase sarm1-like, transcript variant X19
NAD(+) hydrolase sarm1-like, transcript variant X21
NAD(+) hydrolase sarm1-like, transcript variant X14
NAD(+) hydrolase sarm1-like, transcript variant X12
NAD(+) hydrolase sarm1-like, transcript variant X22
NAD(+) hydrolase sarm1-like, transcript variant X18
uncharacterized LOC123519532, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC123519532, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123519532, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC123519532, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123519532, transcript variant X5
uncharacterized LOC123519532, transcript variant X7
uncharacterized LOC123519532, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC123519532, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized protein LOC123519532 isoform X2
uncharacterized protein LOC123519532 isoform X6
uncharacterized protein LOC123519532 isoform X4
uncharacterized protein LOC123519532 isoform X5
uncharacterized protein LOC123519532 isoform X3
uncharacterized protein LOC123519532 isoform X1
uncharacterized protein LOC123519532 isoform X7
WD repeat-containing and planar cell polarity effector protein fritz homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
WD repeat-containing and planar cell polarity effector protein fritz homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
WD repeat-containing and planar cell polarity effector protein fritz homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
WD repeat-containing and planar cell polarity effector protein fritz homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
WD repeat-containing and planar cell polarity effector protein fritz homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
WD repeat-containing and planar cell polarity effector protein fritz homolog isoform X1
WD repeat-containing and planar cell polarity effector protein fritz homolog isoform X2
uncharacterized oxidoreductase YjmC-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
uncharacterized oxidoreductase YjmC-like, transcript variant X1
uncharacterized oxidoreductase YjmC-like, transcript variant X2
uncharacterized oxidoreductase YjmC-like isoform X1
uncharacterized oxidoreductase YjmC-like isoform X2
uncharacterized LOC123519535, transcript variant X11
uncharacterized LOC123519535, transcript variant X8
uncharacterized LOC123519535, transcript variant X5
uncharacterized LOC123519535, transcript variant X2
uncharacterized LOC123519535, transcript variant X7
uncharacterized LOC123519535, transcript variant X10
uncharacterized LOC123519535, transcript variant X4
uncharacterized LOC123519535, transcript variant X6
uncharacterized LOC123519535, transcript variant X9
uncharacterized LOC123519535, transcript variant X3
uncharacterized LOC123519535, transcript variant X1
uncharacterized LOC123519531, transcript variant X1
uncharacterized LOC123519531, transcript variant X2
uncharacterized LOC123519531, transcript variant X3
uncharacterized protein LOC123519531 isoform X2
uncharacterized protein LOC123519531 isoform X1
uncharacterized protein LOC123519531 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
peptide methionine sulfoxide reductase-like
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: peptide methionine sulfoxide reductase-like
uncharacterized LOC123519542, transcript variant X3
uncharacterized LOC123519542, transcript variant X1
uncharacterized LOC123519542, transcript variant X2
GTPase-activating Rap/Ran-GAP domain-like protein 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
GTPase-activating Rap/Ran-GAP domain-like protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
GTPase-activating Rap/Ran-GAP domain-like protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
GTPase-activating Rap/Ran-GAP domain-like protein 3, transcript variant X5
GTPase-activating Rap/Ran-GAP domain-like protein 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
GTPase-activating Rap/Ran-GAP domain-like protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
GTPase-activating Rap/Ran-GAP domain-like protein 3, transcript variant X8
GTPase-activating Rap/Ran-GAP domain-like protein 3, transcript variant X4
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X6
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X5
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X3
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X1
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X7
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X2
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X8
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ATP-dependent RNA helicase DHX33-like, transcript variant X2
ATP-dependent RNA helicase DHX33-like, transcript variant X1
ATP-dependent RNA helicase DHX33-like isoform X1
ATP-dependent RNA helicase DHX33-like isoform X2
probable 39S ribosomal protein L23, mitochondrial
N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase- like, transcript variant X1
N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase- like, transcript variant X2
N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase- like isoform X1
N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase- like isoform X2
serine/arginine-rich splicing factor 3-like, transcript variant X7
serine/arginine-rich splicing factor 3-like, transcript variant X4
uncharacterized protein LOC123519551 isoform X1
uncharacterized protein LOC123519551 isoform X4
serine/arginine-rich splicing factor 3-like, transcript variant X9
serine/arginine-rich splicing factor 3-like, transcript variant X6
serine/arginine-rich splicing factor 3-like, transcript variant X8
serine/arginine-rich splicing factor 3-like, transcript variant X5
serine/arginine-rich splicing factor 3-like, transcript variant X1
serine/arginine-rich splicing factor 3-like isoform X6
serine/arginine-rich splicing factor 3-like isoform X5
serine/arginine-rich splicing factor 3-like, transcript variant X2
serine/arginine-rich splicing factor 3-like, transcript variant X3
serine/arginine-rich splicing factor 3-like isoform X3
serine/arginine-rich splicing factor 3-like isoform X2
coiled-coil domain-containing protein 115-like, transcript variant X1
coiled-coil domain-containing protein 115-like, transcript variant X3
coiled-coil domain-containing protein 115-like, transcript variant X2
coiled-coil domain-containing protein 115-like, transcript variant X4
coiled-coil domain-containing protein 115-like
transmembrane protein 11, mitochondrial-like
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6-like
cytochrome c oxidase assembly factor 5-like, transcript variant X1
cytochrome c oxidase assembly factor 5-like, transcript variant X3
cytochrome c oxidase assembly factor 5-like, transcript variant X2
cytochrome c oxidase assembly factor 5-like
glycerophosphocholine cholinephosphodiesterase ENPP6-like, transcript variant X2
glycerophosphocholine cholinephosphodiesterase ENPP6-like, transcript variant X3
glycerophosphocholine cholinephosphodiesterase ENPP6-like, transcript variant X1
glycerophosphocholine cholinephosphodiesterase ENPP6-like isoform X1
glycerophosphocholine cholinephosphodiesterase ENPP6-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase alpha-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase alpha-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase alpha-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase alpha-like isoform X2
receptor-type tyrosine-protein phosphatase alpha-like isoform X1
venom phosphodiesterase 2-like, transcript variant X2
venom phosphodiesterase 2-like isoform X2
venom phosphodiesterase 2-like, transcript variant X1
venom phosphodiesterase 2-like isoform X1
bifunctional arginine demethylase and lysyl-hydroxylase JMJD6-like
tRNA (guanine-N(7)-)-methyltransferase-like, transcript variant X3
tRNA (guanine-N(7)-)-methyltransferase-like, transcript variant X2
tRNA (guanine-N(7)-)-methyltransferase-like, transcript variant X1
tRNA (guanine-N(7)-)-methyltransferase-like isoform X1
tRNA (guanine-N(7)-)-methyltransferase-like isoform X2
acanthoscurrin-2-like, transcript variant X1
acanthoscurrin-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
tachykinin-like peptides receptor 86C, transcript variant X3
tachykinin-like peptides receptor 86C, transcript variant X2
tachykinin-like peptides receptor 86C, transcript variant X1
tachykinin-like peptides receptor 86C isoform X3
tachykinin-like peptides receptor 86C isoform X2
tachykinin-like peptides receptor 86C isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
high-affinity choline transporter 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
high-affinity choline transporter 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
high-affinity choline transporter 1-like
CAP-Gly domain-containing linker protein 1-like isoform X5
CAP-Gly domain-containing linker protein 1-like isoform X6
CAP-Gly domain-containing linker protein 1-like isoform X4
CAP-Gly domain-containing linker protein 1-like isoform X3
CAP-Gly domain-containing linker protein 1-like isoform X2
CAP-Gly domain-containing linker protein 1-like isoform X1
CAP-Gly domain-containing linker protein 1-like isoform X7
CAP-Gly domain-containing linker protein 1-like isoform X8
CAP-Gly domain-containing linker protein 1-like isoform X9
electron transfer flavoprotein regulatory factor 1-like, transcript variant X1
electron transfer flavoprotein regulatory factor 1-like isoform X1
electron transfer flavoprotein regulatory factor 1-like, transcript variant X2
electron transfer flavoprotein regulatory factor 1-like isoform X2
ubiquitin-like protein 7, transcript variant X3
ubiquitin-like protein 7, transcript variant X2
ubiquitin-like protein 7, transcript variant X1
ubiquitin-like protein 7, transcript variant X5
ubiquitin-like protein 7, transcript variant X6
ubiquitin-like protein 7, transcript variant X4
cytochrome P450 2L1-like, transcript variant X1
cytochrome P450 2L1-like, transcript variant X3
cytochrome P450 2L1-like, transcript variant X2
calcium/calmodulin-dependent protein kinase kinase 1-like, transcript variant X2
calcium/calmodulin-dependent protein kinase kinase 1-like, transcript variant X4
calcium/calmodulin-dependent protein kinase kinase 1-like, transcript variant X1
calcium/calmodulin-dependent protein kinase kinase 1-like, transcript variant X5
calcium/calmodulin-dependent protein kinase kinase 1-like, transcript variant X6
calcium/calmodulin-dependent protein kinase kinase 1-like, transcript variant X3
calcium/calmodulin-dependent protein kinase kinase 1-like isoform X3
calcium/calmodulin-dependent protein kinase kinase 1-like isoform X1
calcium/calmodulin-dependent protein kinase kinase 1-like isoform X4
calcium/calmodulin-dependent protein kinase kinase 1-like isoform X5
calcium/calmodulin-dependent protein kinase kinase 1-like isoform X2
glutamate receptor ionotropic, kainate 5-like, transcript variant X2
glutamate receptor ionotropic, kainate 5-like, transcript variant X1
glutamate receptor ionotropic, kainate 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable nuclear hormone receptor HR3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
probable nuclear hormone receptor HR3 isoform X5
probable nuclear hormone receptor HR3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable nuclear hormone receptor HR3 isoform X3
probable nuclear hormone receptor HR3, transcript variant X7
probable nuclear hormone receptor HR3 isoform X4
probable nuclear hormone receptor HR3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable nuclear hormone receptor HR3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
probable nuclear hormone receptor HR3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
probable nuclear hormone receptor HR3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
probable nuclear hormone receptor HR3, transcript variant X4
probable nuclear hormone receptor HR3 isoform X1
probable nuclear hormone receptor HR3 isoform X2
DNA replication complex GINS protein PSF1-like, transcript variant X2
DNA replication complex GINS protein PSF1-like, transcript variant X1
DNA replication complex GINS protein PSF1-like isoform X1
DNA replication complex GINS protein PSF1-like isoform X2
uncharacterized LOC123519519, transcript variant X1
uncharacterized LOC123519519, transcript variant X2
uncharacterized protein LOC123519519 isoform X1
uncharacterized protein LOC123519519 isoform X2
calcium-activated potassium channel slowpoke-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: calcium-activated potassium channel slowpoke-like
set1/Ash2 histone methyltransferase complex subunit ASH2-like, transcript variant X3
set1/Ash2 histone methyltransferase complex subunit ASH2-like, transcript variant X4
set1/Ash2 histone methyltransferase complex subunit ASH2-like, transcript variant X5
set1/Ash2 histone methyltransferase complex subunit ASH2-like, transcript variant X2
set1/Ash2 histone methyltransferase complex subunit ASH2-like, transcript variant X1
set1/Ash2 histone methyltransferase complex subunit ASH2-like isoform X1
set1/Ash2 histone methyltransferase complex subunit ASH2-like isoform X3
set1/Ash2 histone methyltransferase complex subunit ASH2-like isoform X4
set1/Ash2 histone methyltransferase complex subunit ASH2-like isoform X5
set1/Ash2 histone methyltransferase complex subunit ASH2-like isoform X2
TWiK family of potassium channels protein 18-like
DNA replication complex GINS protein SLD5-like
cortactin-binding protein 2-like, transcript variant X1
cortactin-binding protein 2-like, transcript variant X2
cortactin-binding protein 2-like, transcript variant X3
cortactin-binding protein 2-like isoform X1
cortactin-binding protein 2-like isoform X2
cortactin-binding protein 2-like isoform X3
uncharacterized LOC123519249, transcript variant X1
uncharacterized LOC123519249, transcript variant X2
cysteine and histidine-rich protein 1 homolog, transcript variant X2
cysteine and histidine-rich protein 1 homolog, transcript variant X1
cysteine and histidine-rich protein 1 homolog, transcript variant X3
cysteine and histidine-rich protein 1 homolog isoform X1
cysteine and histidine-rich protein 1 homolog isoform X2
polyadenylate-binding protein 4-like, transcript variant X2
polyadenylate-binding protein 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
flavin-containing monooxygenase FMO GS-OX-like 2
scm-like with four MBT domains protein 2
protein argonaute-2-like, transcript variant X2
protein argonaute-2-like, transcript variant X6
protein argonaute-2-like, transcript variant X5
protein argonaute-2-like, transcript variant X1
protein argonaute-2-like, transcript variant X4
protein argonaute-2-like, transcript variant X3
S-phase kinase-associated protein 2-like
tyrosine-protein kinase transmembrane receptor Ror2-like, transcript variant X1
tyrosine-protein kinase transmembrane receptor Ror2-like, transcript variant X2
tyrosine-protein kinase transmembrane receptor Ror2-like isoform X1
tyrosine-protein kinase transmembrane receptor Ror2-like isoform X2
diacylglycerol kinase eta-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 long SRA reads, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
diacylglycerol kinase eta-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 long SRA reads, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
diacylglycerol kinase eta-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
diacylglycerol kinase eta-like isoform X2
diacylglycerol kinase eta-like isoform X1
diacylglycerol kinase eta-like isoform X3
putative ammonium transporter 3, transcript variant X2
putative ammonium transporter 3, transcript variant X1
putative ammonium transporter 3 isoform X2
putative ammonium transporter 3 isoform X1
uncharacterized LOC123519518, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123519518, transcript variant X1
general transcription factor IIE subunit 1-like, transcript variant X2
general transcription factor IIE subunit 1-like, transcript variant X1
general transcription factor IIE subunit 1-like
uncharacterized LOC123519359, transcript variant X2
uncharacterized LOC123519359, transcript variant X1
uncharacterized protein LOC123519359 isoform X2
uncharacterized protein LOC123519359 isoform X1
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ras-specific guanine nucleotide-releasing factor 2-like isoform X3
ras-specific guanine nucleotide-releasing factor 2-like isoform X2
ras-specific guanine nucleotide-releasing factor 2-like isoform X1
NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial-like
protein YIF1B-B-like, transcript variant X4
protein YIF1B-B-like, transcript variant X2
protein YIF1B-B-like, transcript variant X5
protein YIF1B-B-like, transcript variant X1
protein YIF1B-B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123519273, transcript variant X1
uncharacterized LOC123519273, transcript variant X2
uncharacterized protein LOC123519273 isoform X1
uncharacterized protein LOC123519273 isoform X2
glycine-rich RNA-binding protein 3, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
multidrug resistance-associated protein 1-like
LOW QUALITY PROTEIN: multidrug resistance-associated protein 1-like
alanine--tRNA ligase, cytoplasmic-like, transcript variant X2
alanine--tRNA ligase, cytoplasmic-like, transcript variant X1
alanine--tRNA ligase, cytoplasmic-like isoform X1
alanine--tRNA ligase, cytoplasmic-like, transcript variant X3
alanine--tRNA ligase, cytoplasmic-like isoform X2
NADPH oxidase 5-like, transcript variant X1
NADPH oxidase 5-like, transcript variant X3
NADPH oxidase 5-like, transcript variant X2
gonadotropin-releasing hormone II receptor-like, transcript variant X2
gonadotropin-releasing hormone II receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
gonadotropin-releasing hormone II receptor-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
gonadotropin-releasing hormone II receptor-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gonadotropin-releasing hormone II receptor-like isoform X2
gonadotropin-releasing hormone II receptor-like isoform X1
gonadotropin-releasing hormone II receptor-like isoform X3
gonadotropin-releasing hormone II receptor-like isoform X4
maltase-glucoamylase, intestinal-like, transcript variant X3
maltase-glucoamylase, intestinal-like, transcript variant X2
maltase-glucoamylase, intestinal-like, transcript variant X1
maltase-glucoamylase, intestinal-like isoform X1
maltase-glucoamylase, intestinal-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
maltase-glucoamylase, intestinal-like isoform X2
vitelline membrane outer layer protein 1 homolog
FHA domain-containing protein DDL-like, transcript variant X4
FHA domain-containing protein DDL-like, transcript variant X2
FHA domain-containing protein DDL-like isoform X2
FHA domain-containing protein DDL-like isoform X4
FHA domain-containing protein DDL-like, transcript variant X3
FHA domain-containing protein DDL-like isoform X3
FHA domain-containing protein DDL-like, transcript variant X1
FHA domain-containing protein DDL-like isoform X1
junctional adhesion molecule 2A-like, transcript variant X3
junctional adhesion molecule 2A-like, transcript variant X1
junctional adhesion molecule 2A-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
junctional adhesion molecule 2A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
junctional adhesion molecule 2A-like isoform X1
junctional adhesion molecule 2A-like isoform X3
junctional adhesion molecule 2A-like isoform X4
junctional adhesion molecule 2A-like isoform X2
eukaryotic translation initiation factor 4E-like
biogenesis of lysosome-related organelles complex 1 subunit 4-like, transcript variant X4
biogenesis of lysosome-related organelles complex 1 subunit 4-like, transcript variant X1
biogenesis of lysosome-related organelles complex 1 subunit 4-like, transcript variant X3
biogenesis of lysosome-related organelles complex 1 subunit 4-like, transcript variant X2
biogenesis of lysosome-related organelles complex 1 subunit 4-like isoform X1
biogenesis of lysosome-related organelles complex 1 subunit 4-like isoform X2
methylmalonic aciduria type A homolog, mitochondrial-like
39S ribosomal protein L16, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
pyruvate dehydrogenase protein X component, mitochondrial-like, transcript variant X1
pyruvate dehydrogenase protein X component, mitochondrial-like, transcript variant X2
pyruvate dehydrogenase protein X component, mitochondrial-like isoform X2
pyruvate dehydrogenase protein X component, mitochondrial-like isoform X1
inactive ubiquitin carboxyl-terminal hydrolase MINDY-4B-like, transcript variant X1
inactive ubiquitin carboxyl-terminal hydrolase MINDY-4B-like, transcript variant X2
inactive ubiquitin carboxyl-terminal hydrolase MINDY-4B-like isoform X2
inactive ubiquitin carboxyl-terminal hydrolase MINDY-4B-like isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: GTPase-activating protein CdGAPr-like
cytoplasmic protein NCK1-like, transcript variant X3
cytoplasmic protein NCK1-like, transcript variant X1
cytoplasmic protein NCK1-like, transcript variant X4
cytoplasmic protein NCK1-like, transcript variant X2
cytoplasmic protein NCK1-like, transcript variant X5
cytoplasmic protein NCK1-like isoform X3
cytoplasmic protein NCK1-like isoform X2
cytoplasmic protein NCK1-like isoform X1
cytoplasmic protein NCK1-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phenoloxidase-activating factor 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
phenoloxidase-activating factor 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
phenoloxidase-activating factor 1-like isoform X1
phenoloxidase-activating factor 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
techylectin-5B-like, transcript variant X1
techylectin-5B-like, transcript variant X2
LOW QUALITY PROTEIN: proteoglycan 4-like
uncharacterized LOC123519513, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123519513, transcript variant X1
chloride channel protein-like, transcript variant X3
chloride channel protein-like, transcript variant X2
chloride channel protein-like, transcript variant X4
chloride channel protein-like, transcript variant X1
chloride channel protein 1-like isoform X2
chloride channel protein 1-like isoform X3
chloride channel protein-like isoform X4
chloride channel protein clh-3-like isoform X1
high affinity copper uptake protein 1-like, transcript variant X14
high affinity copper uptake protein 1-like isoform X3
high affinity copper uptake protein 1-like, transcript variant X9
high affinity copper uptake protein 1-like, transcript variant X10
high affinity copper uptake protein 1-like, transcript variant X1
high affinity copper uptake protein 1-like, transcript variant X5
high affinity copper uptake protein 1-like, transcript variant X13
high affinity copper uptake protein 1-like, transcript variant X12
high affinity copper uptake protein 1-like, transcript variant X3
high affinity copper uptake protein 1-like, transcript variant X6
high affinity copper uptake protein 1-like, transcript variant X4
high affinity copper uptake protein 1-like, transcript variant X11
high affinity copper uptake protein 1-like, transcript variant X7
high affinity copper uptake protein 1-like, transcript variant X2
high affinity copper uptake protein 1-like, transcript variant X8
uncharacterized protein LOC123519322 isoform X2
uncharacterized protein LOC123519322 isoform X1
serine proteinase stubble-like, transcript variant X1
serine proteinase stubble-like, transcript variant X2
serine proteinase stubble-like isoform X1
serine proteinase stubble-like isoform X2
short/branched chain specific acyl-CoA dehydrogenase, mitochondrial-like
LOW QUALITY PROTEIN: 60S ribosomal protein L26-like
eclosion hormone-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
eclosion hormone-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
eclosion hormone-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
receptor-binding cancer antigen expressed on SiSo cells-like, transcript variant X2
receptor-binding cancer antigen expressed on SiSo cells-like, transcript variant X1
receptor-binding cancer antigen expressed on SiSo cells-like
uncharacterized LOC123519412, transcript variant X4
uncharacterized LOC123519412, transcript variant X5
uncharacterized LOC123519412, transcript variant X3
uncharacterized LOC123519412, transcript variant X1
uncharacterized LOC123519412, transcript variant X2
uncharacterized protein LOC123519412 isoform X1
uncharacterized protein LOC123519412 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123519605, transcript variant X3
uncharacterized LOC123519605, transcript variant X1
uncharacterized LOC123519605, transcript variant X2
uncharacterized protein LOC123519605 isoform X3
uncharacterized protein LOC123519605 isoform X1
uncharacterized protein LOC123519605 isoform X2
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123519386, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123519386, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
baculoviral IAP repeat-containing protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 long SRA reads, 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
protein kinase C-binding protein NELL2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ribosome-binding protein 1-like, transcript variant X1
ribosome-binding protein 1-like, transcript variant X2
ribosome-binding protein 1-like isoform X2
ribosome-binding protein 1-like isoform X1
probable malonyl-CoA-acyl carrier protein transacylase, mitochondrial
regulation of nuclear pre-mRNA domain-containing protein 1B-like, transcript variant X1
regulation of nuclear pre-mRNA domain-containing protein 1B-like, transcript variant X2
regulation of nuclear pre-mRNA domain-containing protein 1B-like, transcript variant X3
regulation of nuclear pre-mRNA domain-containing protein 1B-like isoform X1
regulation of nuclear pre-mRNA domain-containing protein 1B-like isoform X2
translocon-associated protein subunit delta-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
microtubule-associated serine/threonine-protein kinase 3-like
LOW QUALITY PROTEIN: microtubule-associated serine/threonine-protein kinase 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
probable glycoprotein hormone G-protein coupled receptor
glycine-rich cell wall structural protein 1.8-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
glycine-rich cell wall structural protein-like
dnaJ homolog subfamily C member 5-like, transcript variant X20
dnaJ homolog subfamily C member 5-like, transcript variant X17
dnaJ homolog subfamily C member 5-like, transcript variant X7
dnaJ homolog subfamily C member 5-like, transcript variant X3
dnaJ homolog subfamily C member 5-like, transcript variant X5
dnaJ homolog subfamily C member 5-like, transcript variant X1
dnaJ homolog subfamily C member 5-like, transcript variant X10
dnaJ homolog subfamily C member 5-like, transcript variant X8
dnaJ homolog subfamily C member 5-like, transcript variant X9
dnaJ homolog subfamily C member 5-like, transcript variant X16
dnaJ homolog subfamily C member 5-like, transcript variant X4
dnaJ homolog subfamily C member 5-like, transcript variant X12
dnaJ homolog subfamily C member 5-like, transcript variant X14
dnaJ homolog subfamily C member 5-like, transcript variant X19
dnaJ homolog subfamily C member 5-like, transcript variant X18
dnaJ homolog subfamily C member 5-like, transcript variant X11
dnaJ homolog subfamily C member 5-like, transcript variant X13
dnaJ homolog subfamily C member 5-like, transcript variant X2
dnaJ homolog subfamily C member 5-like, transcript variant X6
dnaJ homolog subfamily C member 5-like, transcript variant X15
dnaJ homolog subfamily C member 5-like isoform X20
dnaJ homolog subfamily C member 5-like isoform X17
dnaJ homolog subfamily C member 5-like isoform X7
dnaJ homolog subfamily C member 5-like isoform X3
dnaJ homolog subfamily C member 5-like isoform X19
dnaJ homolog subfamily C member 5-like isoform X16
dnaJ homolog subfamily C member 5-like isoform X10
dnaJ homolog subfamily C member 5-like isoform X13
dnaJ homolog subfamily C member 5-like isoform X4
dnaJ homolog subfamily C member 5-like isoform X18
dnaJ homolog subfamily C member 5-like isoform X12
dnaJ homolog subfamily C member 5-like isoform X8
dnaJ homolog subfamily C member 5-like isoform X11
dnaJ homolog subfamily C member 5-like isoform X9
dnaJ homolog subfamily C member 5-like isoform X1
dnaJ homolog subfamily C member 5-like isoform X15
dnaJ homolog subfamily C member 5-like isoform X6
dnaJ homolog subfamily C member 5-like isoform X2
dnaJ homolog subfamily C member 5-like isoform X14
dnaJ homolog subfamily C member 5-like isoform X5
coiled-coil domain-containing protein 130 homolog
zwei Ig domain protein zig-8-like, transcript variant X2
zwei Ig domain protein zig-8-like, transcript variant X1
zwei Ig domain protein zig-8-like, transcript variant X4
zwei Ig domain protein zig-8-like, transcript variant X3
uncharacterized LOC123519527, transcript variant X2
uncharacterized LOC123519527, transcript variant X5
uncharacterized LOC123519527, transcript variant X3
uncharacterized LOC123519527, transcript variant X4
uncharacterized LOC123519527, transcript variant X1
uncharacterized protein LOC123519527 isoform X4
uncharacterized protein LOC123519527 isoform X2
uncharacterized protein LOC123519527 isoform X3
uncharacterized protein LOC123519527 isoform X1
peroxisomal sarcosine oxidase-like, transcript variant X2
peroxisomal sarcosine oxidase-like, transcript variant X1
peroxisomal sarcosine oxidase-like isoform X2
peroxisomal sarcosine oxidase-like isoform X1
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cytoskeleton-associated protein 5-like, transcript variant X2
cytoskeleton-associated protein 5-like, transcript variant X1
cytoskeleton-associated protein 5-like, transcript variant X4
cytoskeleton-associated protein 5-like, transcript variant X5
cytoskeleton-associated protein 5-like, transcript variant X6
cytoskeleton-associated protein 5-like, transcript variant X7
cytoskeleton-associated protein 5-like, transcript variant X3
cytoskeleton-associated protein 5-like isoform X1
cytoskeleton-associated protein 5-like isoform X2
cytoskeleton-associated protein 5-like isoform X3
cytoskeleton-associated protein 5-like isoform X5
cytoskeleton-associated protein 5-like isoform X4
nuclear distribution protein nudE-like 1, transcript variant X1
nuclear distribution protein nudE-like 1, transcript variant X2
nuclear distribution protein nudE-like 1, transcript variant X3
nuclear distribution protein nudE-like 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
nuclear distribution protein nudE-like 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
nuclear distribution protein nudE-like 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
nuclear distribution protein nudE-like 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
nuclear distribution protein nudE-like 1, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
nuclear distribution protein nudE-like 1, transcript variant X5
nuclear distribution protein nudE-like 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
nuclear distribution protein nudE-like 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
nuclear distribution protein nudE-like 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
nuclear distribution protein nudE-like 1, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
nuclear distribution protein nudE-like 1, transcript variant X12
nuclear distribution protein nudE-like 1, transcript variant X15
nuclear distribution protein nudE-like 1, transcript variant X14
nuclear distribution protein nudE-like 1 isoform X1
nuclear distribution protein nudE-like 1 isoform X2
nuclear distribution protein nudE-like 1 isoform X3
nuclear distribution protein nudE-like 1 isoform X4
nuclear distribution protein nudE-like 1 isoform X6
nuclear distribution protein nudE-like 1 isoform X5
nuclear distribution protein nudE-like 1 isoform X7
nuclear distribution protein nudE-like 1 isoform X9
nuclear distribution protein nudE-like 1 isoform X10
nuclear distribution protein nudE-like 1 isoform X12
nuclear distribution protein nudE-like 1 isoform X8
nuclear distribution protein nudE-like 1 isoform X11
nuclear distribution protein nudE-like 1 isoform X13
uncharacterized LOC123519673, transcript variant X1
uncharacterized LOC123519673, transcript variant X2
uncharacterized LOC123519673, transcript variant X3
uncharacterized LOC123519673, transcript variant X4
LOW QUALITY PROTEIN: eIF-2-alpha kinase activator GCN1-like
26S proteasome non-ATPase regulatory subunit 14, transcript variant X1
26S proteasome non-ATPase regulatory subunit 14 isoform X1
26S proteasome non-ATPase regulatory subunit 14, transcript variant X2
26S proteasome non-ATPase regulatory subunit 14 isoform X2
uncharacterized LOC123519671, transcript variant X2
uncharacterized LOC123519671, transcript variant X1
uncharacterized protein LOC123519671 isoform X2
uncharacterized protein LOC123519671 isoform X1
regulator of nonsense transcripts 1-like, transcript variant X2
regulator of nonsense transcripts 1-like, transcript variant X1
regulator of nonsense transcripts 1-like isoform X2
regulator of nonsense transcripts 1-like isoform X1
UMP-CMP kinase 1-like, transcript variant X1
UMP-CMP kinase 1-like, transcript variant X2
elongation of very long chain fatty acids protein 6-like, transcript variant X2
elongation of very long chain fatty acids protein 6-like, transcript variant X1
elongation of very long chain fatty acids protein 6-like, transcript variant X3
elongation of very long chain fatty acids protein 6-like isoform X2
elongation of very long chain fatty acids protein 6-like isoform X1
elongation of very long chain fatty acids protein 6-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123519482, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123519482, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123519523, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123519523, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC123519657, transcript variant X2
uncharacterized LOC123519657, transcript variant X3
uncharacterized LOC123519657, transcript variant X1
uncharacterized LOC123519657, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
charged multivesicular body protein 6-A-like
thyroid adenoma-associated protein homolog, transcript variant X1
thyroid adenoma-associated protein homolog, transcript variant X2
thyroid adenoma-associated protein homolog, transcript variant X3
thyroid adenoma-associated protein homolog, transcript variant X4
thyroid adenoma-associated protein homolog isoform X1
thyroid adenoma-associated protein homolog, transcript variant X5
thyroid adenoma-associated protein homolog isoform X2
enoyl-[acyl-carrier-protein] reductase, mitochondrial-like
glycerol-3-phosphate acyltransferase 3-like, transcript variant X3
glycerol-3-phosphate acyltransferase 3-like, transcript variant X1
glycerol-3-phosphate acyltransferase 3-like, transcript variant X2
glycerol-3-phosphate acyltransferase 3-like isoform X3
glycerol-3-phosphate acyltransferase 3-like isoform X2
glycerol-3-phosphate acyltransferase 3-like isoform X1
GRIP and coiled-coil domain-containing protein 2-like
LOW QUALITY PROTEIN: GRIP and coiled-coil domain-containing protein 2-like
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
LOW QUALITY PROTEIN: glucose-6-phosphate isomerase-like
adhesive plaque matrix protein-like, transcript variant X1
adhesive plaque matrix protein-like, transcript variant X2
adhesive plaque matrix protein-like isoform X1
adhesive plaque matrix protein-like isoform X2
ankyrin repeat and SAM domain-containing protein 6-like
LOW QUALITY PROTEIN: ankyrin repeat and SAM domain-containing protein 6-like
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transmembrane protein 151B-like, transcript variant X1
transmembrane protein 151B-like, transcript variant X2
transmembrane protein 151B-like, transcript variant X3
heme-binding protein 2-like, transcript variant X1
heme-binding protein 2-like, transcript variant X2
prostaglandin E2 receptor EP4 subtype-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
SH3 and multiple ankyrin repeat domains protein 1-like
secretion-regulating guanine nucleotide exchange factor-like, transcript variant X1
secretion-regulating guanine nucleotide exchange factor-like, transcript variant X2
secretion-regulating guanine nucleotide exchange factor-like
ras-like protein family member 10B, transcript variant X2
ras-like protein family member 10B, transcript variant X1
FAST kinase domain-containing protein 3, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
MTRF1L release factor glutamine methyltransferase-like, transcript variant X4
MTRF1L release factor glutamine methyltransferase-like, transcript variant X1
MTRF1L release factor glutamine methyltransferase-like, transcript variant X2
MTRF1L release factor glutamine methyltransferase-like, transcript variant X3
MTRF1L release factor glutamine methyltransferase-like
probable serine/threonine-protein kinase dyrk2, transcript variant X2
probable serine/threonine-protein kinase dyrk2, transcript variant X1
probable serine/threonine-protein kinase dyrk2 isoform X2
probable serine/threonine-protein kinase dyrk2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cysteine protease ATG4B-like, transcript variant X3
cysteine protease ATG4B-like, transcript variant X2
cysteine protease ATG4B-like, transcript variant X4
cysteine protease ATG4B-like, transcript variant X1
cystathionine gamma-lyase-like, transcript variant X2
cystathionine gamma-lyase-like, transcript variant X1
cystathionine gamma-lyase-like, transcript variant X3
cystathionine gamma-lyase-like isoform X1
cystathionine gamma-lyase-like isoform X2
histone-lysine N-methyltransferase NSD2-like, transcript variant X3
histone-lysine N-methyltransferase NSD2-like, transcript variant X2
histone-lysine N-methyltransferase NSD2-like, transcript variant X6
histone-lysine N-methyltransferase NSD2-like, transcript variant X1
histone-lysine N-methyltransferase NSD2-like, transcript variant X5
histone-lysine N-methyltransferase NSD2-like, transcript variant X4
histone-lysine N-methyltransferase NSD2-like isoform X2
histone-lysine N-methyltransferase NSD2-like isoform X1
histone-lysine N-methyltransferase NSD2-like isoform X4
histone-lysine N-methyltransferase NSD2-like isoform X3
histone-lysine N-methyltransferase NSD2-like isoform X5
kinesin-like protein KIF3B, transcript variant X2
kinesin-like protein KIF3B, transcript variant X1
GPI ethanolamine phosphate transferase 2-like
LOW QUALITY PROTEIN: GPI ethanolamine phosphate transferase 2-like
uncharacterized LOC123519467, transcript variant X1
uncharacterized LOC123519467, transcript variant X2
uncharacterized protein LOC123519467 isoform X1
uncharacterized protein LOC123519467 isoform X2
myelin expression factor 2-like, transcript variant X2
myelin expression factor 2-like, transcript variant X4
myelin expression factor 2-like, transcript variant X1
myelin expression factor 2-like, transcript variant X3
myelin expression factor 2-like isoform X1
myelin expression factor 2-like isoform X2
geranylgeranyl transferase type-1 subunit beta-like, transcript variant X4
geranylgeranyl transferase type-1 subunit beta-like, transcript variant X1
geranylgeranyl transferase type-1 subunit beta-like, transcript variant X2
geranylgeranyl transferase type-1 subunit beta-like, transcript variant X3
geranylgeranyl transferase type-1 subunit beta-like isoform X2
geranylgeranyl transferase type-1 subunit beta-like isoform X1
geranylgeranyl transferase type-1 subunit beta-like isoform X3
acetylcholinesterase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
acetylcholinesterase-like, transcript variant X1
acetylcholinesterase-like, transcript variant X2
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like, transcript variant X8
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like, transcript variant X1
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like, transcript variant X13
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like, transcript variant X4
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like, transcript variant X3
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like, transcript variant X2
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like, transcript variant X9
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like, transcript variant X7
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like, transcript variant X6
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like, transcript variant X10
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like isoform X7
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase-like isoform X12
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like isoform X1
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like isoform X3
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like isoform X8
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like isoform X6
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like isoform X2
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like isoform X5
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like isoform X9
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like, transcript variant X5
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like, transcript variant X11
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like, transcript variant X12
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like isoform X4
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like isoform X10
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2-like isoform X11
polycystin-2-like, transcript variant X1
polycystin-2-like, transcript variant X2
polycystin-2-like, transcript variant X3
polycystin-2-like, transcript variant X4
polycystic kidney disease 2-like 1 protein isoform X2
polycystic kidney disease 2-like 1 protein isoform X1
inactive selenide, water dikinase-like protein
clathrin heavy chain 1-like, transcript variant X2
clathrin heavy chain 1-like, transcript variant X1
uncharacterized LOC123519318, transcript variant X5
uncharacterized LOC123519318, transcript variant X2
uncharacterized LOC123519318, transcript variant X4
uncharacterized LOC123519318, transcript variant X3
uncharacterized LOC123519318, transcript variant X1
uncharacterized protein LOC123519318 isoform X2
uncharacterized protein LOC123519318 isoform X3
uncharacterized protein LOC123519318 isoform X1
uncharacterized protein LOC123519318 isoform X4
LOW QUALITY PROTEIN: DNA primase large subunit-like
uncharacterized LOC123519483, transcript variant X2
uncharacterized LOC123519483, transcript variant X1
tax1-binding protein 1 homolog B-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
tax1-binding protein 1 homolog B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
tax1-binding protein 1 homolog B-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 5 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
tax1-binding protein 1 homolog B-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
tax1-binding protein 1 homolog B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
tax1-binding protein 1 homolog B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
tax1-binding protein 1 homolog B-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
tax1-binding protein 1 homolog B-like isoform X6
uncharacterized protein LOC123519334 isoform X3
uncharacterized protein LOC123519334 isoform X5
uncharacterized protein LOC123519334 isoform X4
uncharacterized protein LOC123519334 isoform X2
tax1-binding protein 1 homolog B-like isoform X1
uncharacterized protein LOC123519334 isoform X7
fatty-acid amide hydrolase 2-A-like, transcript variant X10
fatty-acid amide hydrolase 2-A-like, transcript variant X1
fatty-acid amide hydrolase 2-A-like, transcript variant X9
fatty-acid amide hydrolase 2-A-like, transcript variant X11
fatty-acid amide hydrolase 2-A-like, transcript variant X3
fatty-acid amide hydrolase 2-A-like, transcript variant X2
fatty-acid amide hydrolase 2-A-like, transcript variant X7
fatty-acid amide hydrolase 2-A-like, transcript variant X8
fatty-acid amide hydrolase 2-A-like, transcript variant X5
fatty-acid amide hydrolase 2-A-like, transcript variant X6
fatty-acid amide hydrolase 2-A-like, transcript variant X4
histone-lysine N-methyltransferase SUV39H2-like
fatty-acid amide hydrolase 2-A-like isoform X1
fatty-acid amide hydrolase 2-A-like isoform X3
fatty-acid amide hydrolase 2-A-like isoform X2
fatty-acid amide hydrolase 2-A-like isoform X4
uncharacterized LOC123519677, transcript variant X4
uncharacterized LOC123519677, transcript variant X2
uncharacterized LOC123519677, transcript variant X1
uncharacterized LOC123519677, transcript variant X3
uncharacterized LOC123519677, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cilia- and flagella-associated protein 251-like, transcript variant X1
cilia- and flagella-associated protein 251-like, transcript variant X2
cilia- and flagella-associated protein 251-like isoform X2
cilia- and flagella-associated protein 251-like isoform X1
mediator of RNA polymerase II transcription subunit 17-like, transcript variant X1
mediator of RNA polymerase II transcription subunit 17-like, transcript variant X2
mediator of RNA polymerase II transcription subunit 17-like isoform X2
mediator of RNA polymerase II transcription subunit 17-like isoform X1
vacuolar protein sorting-associated protein 11 homolog
proton channel OtopLc-like, transcript variant X2
proton channel OtopLc-like, transcript variant X5
proton channel OtopLc-like, transcript variant X7
proton channel OtopLc-like, transcript variant X3
proton channel OtopLc-like, transcript variant X4
proton channel OtopLc-like, transcript variant X1
proton channel OtopLc-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
WD40 repeat-containing protein SMU1-like
endoplasmic reticulum-Golgi intermediate compartment protein 2-like, transcript variant X1
endoplasmic reticulum-Golgi intermediate compartment protein 2-like, transcript variant X2
endoplasmic reticulum-Golgi intermediate compartment protein 2-like, transcript variant X3
endoplasmic reticulum-Golgi intermediate compartment protein 2-like, transcript variant X4
endoplasmic reticulum-Golgi intermediate compartment protein 2-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: telomere-associated protein RIF1-like
cyclin-dependent kinase 14-like, transcript variant X4
cyclin-dependent kinase 14-like, transcript variant X6
cyclin-dependent kinase 14-like isoform X4
cyclin-dependent kinase 14-like isoform X6
cyclin-dependent kinase 14-like, transcript variant X1
cyclin-dependent kinase 14-like, transcript variant X3
cyclin-dependent kinase 14-like, transcript variant X5
cyclin-dependent kinase 14-like, transcript variant X15
cyclin-dependent kinase 14-like, transcript variant X2
cyclin-dependent kinase 14-like, transcript variant X18
cyclin-dependent kinase 14-like, transcript variant X17
cyclin-dependent kinase 14-like, transcript variant X21
cyclin-dependent kinase 14-like isoform X1
cyclin-dependent kinase 14-like isoform X2
cyclin-dependent kinase 14-like isoform X5
cyclin-dependent kinase 14-like isoform X10
cyclin-dependent kinase 14-like isoform X13
cyclin-dependent kinase 14-like isoform X3
cyclin-dependent kinase 14-like isoform X8
cyclin-dependent kinase 14-like isoform X11
cyclin-dependent kinase 14-like, transcript variant X14
cyclin-dependent kinase 14-like, transcript variant X10
cyclin-dependent kinase 14-like, transcript variant X7
cyclin-dependent kinase 14-like, transcript variant X16
cyclin-dependent kinase 14-like, transcript variant X19
cyclin-dependent kinase 14-like, transcript variant X8
cyclin-dependent kinase 14-like, transcript variant X9
cyclin-dependent kinase 14-like, transcript variant X11
cyclin-dependent kinase 14-like, transcript variant X12
cyclin-dependent kinase 14-like, transcript variant X13
cyclin-dependent kinase 14-like, transcript variant X20
cyclin-dependent kinase 14-like isoform X7
cyclin-dependent kinase 14-like isoform X9
cyclin-dependent kinase 14-like isoform X12
uncharacterized LOC123519341, transcript variant X1
uncharacterized LOC123519341, transcript variant X2
uncharacterized protein LOC123519341 isoform X1
uncharacterized protein LOC123519341 isoform X2
GDP-fucose protein O-fucosyltransferase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized LOC123519340, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123519340, transcript variant X2
uncharacterized LOC123519340, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC123519340 isoform X2
uncharacterized protein LOC123519340 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial ribonuclease P protein 1 homolog
signaling mucin HKR1-like, transcript variant X5
signaling mucin HKR1-like, transcript variant X4
signaling mucin HKR1-like, transcript variant X3
signaling mucin HKR1-like, transcript variant X6
signaling mucin HKR1-like, transcript variant X2
signaling mucin HKR1-like, transcript variant X1
tigger transposable element-derived protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
required for meiotic nuclear division protein 1 homolog
m-AAA protease-interacting protein 1, mitochondrial-like
FAST kinase domain-containing protein 5, mitochondrial-like, transcript variant X2
FAST kinase domain-containing protein 5, mitochondrial-like, transcript variant X1
FAST kinase domain-containing protein 5, mitochondrial-like
rhomboid-related protein 2-like, transcript variant X1
rhomboid-related protein 2-like, transcript variant X3
rhomboid-related protein 2-like, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
LOW QUALITY PROTEIN: required for meiotic nuclear division protein 1 homolog
pleckstrin homology domain-containing family F member 2-like, transcript variant X3
pleckstrin homology domain-containing family F member 2-like, transcript variant X6
pleckstrin homology domain-containing family F member 2-like, transcript variant X1
pleckstrin homology domain-containing family F member 2-like, transcript variant X7
pleckstrin homology domain-containing family F member 2-like, transcript variant X5
pleckstrin homology domain-containing family F member 2-like, transcript variant X2
pleckstrin homology domain-containing family F member 2-like, transcript variant X4
pleckstrin homology domain-containing family F member 2-like isoform X3
pleckstrin homology domain-containing family F member 2-like isoform X7
pleckstrin homology domain-containing family F member 2-like isoform X6
pleckstrin homology domain-containing family F member 2-like isoform X1
pleckstrin homology domain-containing family F member 2-like isoform X4
pleckstrin homology domain-containing family F member 2-like isoform X2
pleckstrin homology domain-containing family F member 2-like isoform X5
geranylgeranyl pyrophosphate synthase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
geranylgeranyl pyrophosphate synthase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
geranylgeranyl pyrophosphate synthase-like
dynein axonemal intermediate chain 7 homolog
uncharacterized histidine-rich protein DDB_G0274557-like
UDP-glucuronic acid decarboxylase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
UDP-glucuronic acid decarboxylase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
UDP-glucuronic acid decarboxylase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
UDP-glucuronic acid decarboxylase 1-like
organic cation transporter protein-like, transcript variant X8
organic cation transporter protein-like, transcript variant X3
organic cation transporter protein-like, transcript variant X2
organic cation transporter protein-like, transcript variant X1
organic cation transporter protein-like, transcript variant X4
organic cation transporter protein-like, transcript variant X5
organic cation transporter protein-like, transcript variant X7
organic cation transporter protein-like, transcript variant X6
organic cation transporter protein-like isoform X7
organic cation transporter protein-like isoform X2
organic cation transporter protein-like isoform X1
organic cation transporter protein-like isoform X3
organic cation transporter protein-like isoform X4
organic cation transporter protein-like isoform X6
organic cation transporter protein-like isoform X5
organic cation transporter protein-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
organic cation transporter protein-like isoform X8
protein FAM177B-like, transcript variant X2
protein FAM177B-like, transcript variant X3
protein FAM177B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 3 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized protein LOC123519478 isoform X1
uncharacterized LOC123519288, transcript variant X1
uncharacterized LOC123519288, transcript variant X3
uncharacterized LOC123519288, transcript variant X2
uncharacterized protein LOC123519288 isoform X1
uncharacterized protein LOC123519288 isoform X2
uncharacterized LOC123519288, transcript variant X4
uncharacterized protein LOC123519288 isoform X3
XK-related protein 8-like, transcript variant X1
XK-related protein 8-like, transcript variant X5
XK-related protein 8-like, transcript variant X6
XK-related protein 8-like, transcript variant X2
uncharacterized protein LOC123519291 isoform X4
XK-related protein 8-like, transcript variant X3
XK-related protein 8-like, transcript variant X4
zinc finger protein OZF-like, transcript variant X1
zinc finger protein OZF-like, transcript variant X2
zinc finger protein OZF-like, transcript variant X3
zinc finger protein OZF-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
octopamine receptor beta-1R-like, transcript variant X2
octopamine receptor beta-1R-like, transcript variant X1
uncharacterized LOC123519298, transcript variant X3
uncharacterized LOC123519298, transcript variant X2
uncharacterized LOC123519298, transcript variant X1
sodium-dependent serotonin transporter-like, transcript variant X2
sodium-dependent serotonin transporter-like, transcript variant X3
sodium-dependent serotonin transporter-like, transcript variant X1
sodium-dependent serotonin transporter-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like isoform X1
sodium-dependent serotonin transporter-like isoform X3
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like isoform X2
adenosine kinase-like, transcript variant X1
adenosine kinase-like, transcript variant X2
adenosine kinase-like, transcript variant X3
oplophorus-luciferin 2-monooxygenase non-catalytic subunit-like, transcript variant X2
oplophorus-luciferin 2-monooxygenase non-catalytic subunit-like, transcript variant X1
oplophorus-luciferin 2-monooxygenase non-catalytic subunit-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC123519304
protein transport protein Sec24A-like, transcript variant X2
protein transport protein Sec24A-like, transcript variant X1
protein transport protein Sec24A-like, transcript variant X3
protein transport protein Sec24A-like isoform X1
protein transport protein Sec24A-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
differentially expressed in FDCP 8 homolog A-like, transcript variant X3
differentially expressed in FDCP 8 homolog A-like, transcript variant X6
differentially expressed in FDCP 8 homolog A-like, transcript variant X7
differentially expressed in FDCP 8 homolog A-like, transcript variant X5
differentially expressed in FDCP 8 homolog A-like, transcript variant X4
differentially expressed in FDCP 8 homolog A-like, transcript variant X1
differentially expressed in FDCP 8 homolog A-like, transcript variant X8
differentially expressed in FDCP 8 homolog A-like, transcript variant X2
differentially expressed in FDCP 8 homolog A-like isoform X4
differentially expressed in FDCP 8 homolog A-like isoform X5
differentially expressed in FDCP 8 homolog A-like isoform X3
differentially expressed in FDCP 8 homolog A-like isoform X2
differentially expressed in FDCP 8 homolog A-like isoform X1
differentially expressed in FDCP 8 homolog A-like isoform X6
solute carrier organic anion transporter family member 74D-like, transcript variant X3
solute carrier organic anion transporter family member 74D-like, transcript variant X4
solute carrier organic anion transporter family member 74D-like, transcript variant X2
solute carrier organic anion transporter family member 74D-like, transcript variant X1
solute carrier organic anion transporter family member 74D-like isoform X2
solute carrier organic anion transporter family member 74D-like isoform X1
solute carrier organic anion transporter family member 74D-like isoform X3
uncharacterized LOC123519310, transcript variant X2
uncharacterized LOC123519310, transcript variant X1
protein phosphatase 1 regulatory subunit 16A-like
LOW QUALITY PROTEIN: protein phosphatase 1 regulatory subunit 16A-like
probable dimethyladenosine transferase, transcript variant X2
probable dimethyladenosine transferase, transcript variant X3
probable dimethyladenosine transferase, transcript variant X1
probable dimethyladenosine transferase isoform X1
probable dimethyladenosine transferase isoform X2
prominin-1-A-like, transcript variant X2
prominin-1-A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
RNA-binding protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
RNA-binding protein 1-like, transcript variant X4
RNA-binding protein 1-like, transcript variant X6
RNA-binding protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 long SRA reads, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
RNA-binding protein 1-like, transcript variant X3
RNA-binding protein 1-like, transcript variant X5
lanC-like protein 3 homolog, transcript variant X1
lanC-like protein 3 homolog, transcript variant X2
serine/arginine repetitive matrix protein 2-like, transcript variant X1
serine/arginine repetitive matrix protein 2-like isoform X1
serine/arginine repetitive matrix protein 2-like, transcript variant X2
serine/arginine repetitive matrix protein 2-like isoform X2
histidine decarboxylase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
histidine decarboxylase-like, transcript variant X2
uncharacterized LOC123519629, transcript variant X1
uncharacterized LOC123519629, transcript variant X2
zinc transporter 1-like, transcript variant X7
zinc transporter 1-like, transcript variant X9
zinc transporter 1-like, transcript variant X8
zinc transporter 1-like, transcript variant X6
zinc transporter 1-like, transcript variant X2
zinc transporter 1-like, transcript variant X3
zinc transporter 1-like, transcript variant X5
zinc transporter 1-like, transcript variant X4
zinc transporter 1-like, transcript variant X1
zinc/cadmium resistance protein-like isoform X1
trithorax group protein osa-like, transcript variant X2
trithorax group protein osa-like, transcript variant X1
trithorax group protein osa-like isoform X1
trithorax group protein osa-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
trithorax group protein osa-like isoform X2
DNA-directed RNA polymerase II subunit RPB2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-like, transcript variant X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-like, transcript variant X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-like, transcript variant X4
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-like, transcript variant X5
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-like isoform X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-like isoform X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-like isoform X4
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-like isoform X5
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-like, transcript variant X3
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-like isoform X3
UPF0545 protein C22orf39 homolog, transcript variant X1
UPF0545 protein C22orf39 homolog, transcript variant X2
zinc finger protein 33B-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
zinc finger protein 33B-like, transcript variant X1
zinc finger protein 33B-like, transcript variant X2
zinc finger protein 33B-like, transcript variant X4
zinc finger protein 33B-like, transcript variant X3
uncharacterized LOC123519330, transcript variant X2
uncharacterized protein LOC123519330 isoform X2
uncharacterized LOC123519330, transcript variant X1
uncharacterized protein LOC123519330 isoform X1
succinate--hydroxymethylglutarate CoA-transferase-like, transcript variant X2
succinate--hydroxymethylglutarate CoA-transferase-like, transcript variant X1
succinate--hydroxymethylglutarate CoA-transferase-like isoform X1
succinate--hydroxymethylglutarate CoA-transferase-like isoform X2
carbohydrate sulfotransferase 11-like, transcript variant X6
carbohydrate sulfotransferase 11-like, transcript variant X4
carbohydrate sulfotransferase 11-like, transcript variant X3
carbohydrate sulfotransferase 11-like, transcript variant X5
carbohydrate sulfotransferase 11-like, transcript variant X1
carbohydrate sulfotransferase 11-like, transcript variant X2
carbohydrate sulfotransferase 11-like isoform X1
carbohydrate sulfotransferase 11-like isoform X2
zwei Ig domain protein zig-8-like isoform X1
zwei Ig domain protein zig-8-like isoform X2
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
DNA (cytosine-5)-methyltransferase 1-like
glycine receptor subunit alphaZ1-like, transcript variant X2
glycine receptor subunit alphaZ1-like, transcript variant X1
glycine receptor subunit alphaZ1-like, transcript variant X3
glycine receptor subunit alphaZ1-like isoform X1
glycine receptor subunit alpha-2-like isoform X2
transfer RNA valine (anticodon GAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1-like
60S ribosomal protein L9-like, transcript variant X1
60S ribosomal protein L9-like, transcript variant X2
tether containing UBX domain for GLUT4-like, transcript variant X1
tether containing UBX domain for GLUT4-like, transcript variant X2
tether containing UBX domain for GLUT4-like, transcript variant X3
tether containing UBX domain for GLUT4-like isoform X2
tether containing UBX domain for GLUT4-like isoform X1
tether containing UBX domain for GLUT4-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 long SRA reads, 6 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments